China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use

China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.

Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.